Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
17.57
-1.42 (-7.48%)
At close: Nov 5, 2026, 4:00 PM EST
17.18
-0.39 (-2.22%)
After-hours: Nov 5, 2026, 7:55 PM EST

Sarepta Therapeutics Revenue

Sarepta Therapeutics had revenue of $381.35M in the quarter ending September 30, 2026, a decrease of -4.51%. This brings the company's total for the last twelve months to $1.96B, down -18.95% year-over-year. In the year 2025, Sarepta Therapeutics had annual revenue of $2.20B with 15.58% growth. That makes Sarepta Therapeutics the 5,010th largest company in the world by revenue and 1,299th in the United States.

Revenue (ttm)
$1.96B
Revenue Growth
-18.95%
P/S Ratio
0.95
Revenue / Employee
$2,342,921
Employees
835
Market Cap
1.86B

Revenue Chart

Revenue by Segment

  • Total PMO Products 965.57M 43.9%
  • ELEVIDYS 898.73M 40.9%
  • Collaboration and Other 333.94M 15.2%
Fiscal year ended Dec 31, 2025 See the full Sarepta Therapeutics breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.20B296.26M15.58%
Dec 31, 20241.90B658.64M52.97%
Dec 31, 20231.24B310.32M33.26%
Dec 31, 2022933.01M231.13M32.93%
Dec 31, 2021701.89M161.79M29.96%
Dec 31, 2020540.10M159.27M41.82%
Dec 31, 2019380.83M79.80M26.51%
Dec 31, 2018301.03M146.45M94.74%
Dec 31, 2017154.58M149.16M2,751.58%
Dec 31, 20165.42M4.17M332.64%
Dec 31, 20151.25M-8.50M-87.16%
Dec 31, 20149.76M-4.46M-31.38%
Dec 31, 201314.22M-23.11M-61.91%
Dec 31, 201237.33M-9.66M-20.56%
Dec 31, 201146.99M17.57M59.72%
Dec 31, 201029.42M11.84M67.30%
Dec 31, 200917.59M-3.67M-17.28%
Dec 31, 200821.26M10.27M93.52%
Dec 31, 200710.99M10.87M9,428.06%
Dec 31, 2006115.29K-4.67M-97.59%
Dec 31, 20054.78M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.